NTRR Leadership Travels to Colorado to Strike Product Testing Deals With Cannabis Farmers

Representatives from Neutra Corp. (OTCBB: NTRR) and its joint venture partner, Surface to Air Solutions (S2O2), traveled to Colorado this week seeking out new product testing partnerships with local cannabis farmers.

As one of the nation’s top markets for cannabis and its cultivation, Colorado is home to some of the world’s most innovative growers. That makes it the perfect place to test out and demonstrate the joint venture’s suite of market-ready agricultural technologies, said NTRR CEO Chris Brown.

“We’ve already had a very productive meeting with one of the most respected and established growers in Denver,” Brown said. “Colorado, obviously, is on the cutting edge of this industry. S2O2 has developed some very exciting products that we believe are poised to change the way cannabis is cultivated there.”

NTRR is seeking out new partners in the Centennial State to help test and improve antimicrobial products created by S202 to eliminate germs and odors from a wide variety of businesses and institutions where sanitation is paramount. When applied to surfaces, S2O2’s environmentally friendly formulas form an invisible, long-lasting coating that actively protects surfaces from the build-up of organic matter—including bacteria, molds, germs and allergens.

NTRR believes it is an ideal solution to growers that are wary of using pesticides and other harsh chemicals on or near their crops. S2O2’s suite of products is already being tested in California and Canada.

The outreach to farmers this week is only the next step in NTRR’s plan to bring enticing new innovations to a multi-billion-dollar cannabis industry that was the fastest-growing sector of the U.S. economy last year.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.